Ferguson Morag, Wilkinson Dianna E, Zhou TieQun
National Institute for Biological Standards and Control (NIBSC), UK.
Vaccine. 2009 Jan 14;27(3):337-47. doi: 10.1016/j.vaccine.2008.10.062. Epub 2008 Nov 11.
In anticipation of the implementation of new prophylactic HPV vaccines, the WHO is supporting the establishment of a global WHO HPV Laboratory Network whose mission is to "contribute to improving the quality of laboratory services for effective surveillance and monitoring of HPV vaccination impact through enhanced, state-of-the-art laboratory support". WHO convened a meeting at its headquarters, 24-25 January 2008 which placed particular emphasis on the harmonization of HPV Laboratory Network practices and standardization of HPV assays as these are crucial for the success of the HPV Laboratory Network in conducting studies measuring HPV disease burden and vaccine impact. To assist the HPV Laboratory Network in fulfilling its mission, the meeting was attended by all members of the HPV Laboratory Network, representatives of WHO Headquarters and Regional Offices, WHO Collaborating Centres involved in HPV-related work as well as experts from additional HPV laboratories around the world, representatives of national regulatory and control authorities, non-profit organizations and the vaccine industry.
为筹备新型预防性人乳头瘤病毒（HPV）疫苗的实施，世界卫生组织（WHO）正在支持建立一个全球WHO HPV实验室网络，其使命是“通过加强先进的实验室支持，为提高实验室服务质量以有效监测和评估HPV疫苗接种效果做出贡献”。WHO于2008年1月24日至25日在其总部召开了一次会议，特别强调了HPV实验室网络操作的协调统一以及HPV检测方法的标准化，因为这些对于HPV实验室网络成功开展衡量HPV疾病负担和疫苗效果的研究至关重要。为协助HPV实验室网络履行其使命，HPV实验室网络的所有成员、WHO总部和区域办事处的代表、参与HPV相关工作的WHO合作中心以及来自世界各地其他HPV实验室的专家、国家监管当局、非营利组织和疫苗行业的代表参加了此次会议。
